NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
SPRAVATO® (esketamine) Nasal Spray FAQs
By: Mitchell Whigham, PA-C
Physician Assistant, Greenbrook Mental Wellness Centers
SPRAVATO® FAQs
Q: What should I do to prepare for my first treatment?
A: We recommend refraining from eating anything for two hours prior to your appointment. I would also recommend bringing any comfort items such as a blanket, pillow or headphones to listen to music.
Q: How long to the side effects last?
A: Typically, side effects peak around 40 minutes after dosing with SPRAVATO®. For the majority of people, side effects generally wear off by the end of the two-hour observation period. However, for some, it may be longer or shorter than that.
Q: What do people do during the two-hour observation period?
A: Journaling, sleeping, drawing, painting, watching a movie, listening to music or podcasts are the most common things I see people do during the observation period.
Q: If I don't really get any side effects, do I have to stay the whole two hours for observation?
A: Yes! The two-hour observation period is mandatory regardless of side effects.
Q: Am I able to drive myself home after treatment?
A: No! Do not operate a vehicle or any machinery after treatment with SPRAVATO® for the rest of the day.
Q: What will SPRAVATO® taste like?
A: Most people tell me there is a bitter or metallic taste to SPRAVATO®. Ask your Greenbrook Care Team what amenities they may have to help with the taste, such as ginger ale or mints!
Q: What if I need to go to the bathroom during the observation period?
A: Be sure to let a member of your Greenbrook Care Team that you need to use the restroom. A member of the team will help escort you to and from the restroom.
Q: Does Greenbrook provide IV ketamine treatments?
A: No, Greenbrook does not provide IV ketamine treatments. IV ketamine has not been approved by the FDA for the treatment of depression.
Q: I have a teenager who I think could benefit from SPRAVATO® treatments, do you treat adolescents?
A: SPRAVATO® is approved for and has only been studied in people over the age of 18 at this time.
Depression is already frustrating, even more so after trying multiple medications that don’t help. If you struggle with treatment resistant depression, it may be time to talk to your Doctor about SPRAVATO® or visit GreenbrookTMS.com to learn more.
Let's see if we might be a good fit
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Share this post
We're Better Together
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Contact Us
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
You might also like
Jackie's Success With NeuroStar® TMS Therapy at Greenbrook
Watch Kimberly's inspiring journey as she shares how Greenbrook's Care Team and NeuroStar TMS helped her reclaim her life.
Andrew's Breakthrough in Treating Depression That Didn't Respond to Medication
At just 20 years old, Chloe found herself struggling with depression—a challenge that made everyday life feel overwhelming and joy hard to find. Working as a Behavioral Health Technician at Greenbrook Mental Wellness Centers, she had witnessed firsthand how NeuroStar® TMS therapy helped patients improve. It was that experience that ultimately led her to seek treatment for herself. Chloe's decision marked a turning point. She responded remarkably well to NeuroStar® TMS, echoing the very outcomes she used to celebrate in others. What followed was a transformation not only in her mental health but in her overall experience of young adulthood. The Care Team at Greenbrook played an essential role in her recovery. Chloe described the Care Team as “absolutely amazing,” noting their kindness and commitment to checking in regularly. Their support made the treatment process feel less clinical and more personal—a space of trust and comfort she looked forward to each day. As treatment progressed, the changes in Chloe’s life began to blossom. She found herself embracing experiences she once would’ve dismissed. One particular moment that stands out is a pottery class she took with a friend—except this wasn’t just any pottery class. It included cuddling baby goats and lambs while painting.
